Advisory Research’s Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 RONI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100,000
Closed -$125K 422
2022
Q4
$125K Buy
+100,000
New +$45.2K 0.01% 348

Other funds holding RONI.WS

Advisory Research's RONI.WS Position: Q1 2023 in Review

Advisory Research sold out of Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (RONI.WS) in Q1 2023, closing a stake of 100,000 shares — an estimated $125K sold.

Advisory Research first reported a position in RONI.WS in Q4 2022 and held it in 1 quarter. The position peaked at $125K in Q4 2022. 34 funds tracked by Wall St. Rank hold RONI.WS as of Q1 2023.

  • Advisory Research reported no remaining Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
  • Advisory Research sold 100,000 Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2023, an estimated $125K.
  • Advisory Research first reported a position in Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2022 and held it in 1 quarter.
  • Advisory Research's Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $125K in Q4 2022.
  • 34 funds tracked by Wall St. Rank held Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2023.

Based on Advisory Research's 13F filing for Q1 2023, filed 12 May 2023.